Complete versus culprit-vessel only revascularization in STEMI: An updated meta-analysis of randomized control trials

[1]  Jennifer E. Moore,et al.  Agency for Healthcare Research and Quality , 2020, Definitions.

[2]  M. Keltai,et al.  Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial. , 2019, Journal of the American College of Cardiology.

[3]  Á. Avezum,et al.  Complete Revascularization with Multivessel PCI for Myocardial Infarction. , 2019, The New England journal of medicine.

[4]  D. Mark,et al.  Acute and 1‐Year Hospitalization Costs for Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention: Results From the TRANSLATE‐ACS Registry , 2019, Journal of the American Heart Association.

[5]  Marco Valgimigli,et al.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.

[6]  G. Stefanini,et al.  Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction. , 2017, The New England journal of medicine.

[7]  F. Neumann,et al.  Fractional Flow Reserve‐Guided Multivessel Angioplasty in Myocardial Infarction , 2017, The New England journal of medicine.

[8]  Deepak L. Bhatt,et al.  Complete or Culprit-Only Revascularization for Patients With Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis of Randomized Trials. , 2017, JACC. Cardiovascular interventions.

[9]  I. Elgendy,et al.  TCT-139 A randomized trial of complete versus culprit-only revascularization during primary percutaneous coronary intervention in diabetic patients with acute ST elevation myocardial infarction and multi vessel disease. , 2016, Journal of the American College of Cardiology.

[10]  S. Aslibekyan,et al.  Comparison of Approaches to Revascularization in Patients With Multivessel Coronary Artery Disease Presenting With ST‐Segment Elevation Myocardial Infarction: Meta‐analyses of Randomized Control Trials , 2015, Journal of the American Heart Association.

[11]  L. Køber,et al.  Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial , 2015, The Lancet.

[12]  H. Swanton,et al.  Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease , 2015, Journal of the American College of Cardiology.

[13]  O. Barbarash,et al.  Six month results of randomized clinical trial: Multivessel stenting versus staged revascularization for ST-elevation myocardial infarction patients with second generation drug eluting stents , 2014 .

[14]  C. Berry,et al.  Randomized trial of preventive angioplasty in myocardial infarction. , 2013, The New England journal of medicine.

[15]  J. Ottervanger,et al.  Treatment of non-culprit lesions detected during primary PCI: long-term follow-up of a randomised clinical trial , 2012, Netherlands Heart Journal.

[16]  P. Cochat,et al.  Et al , 2008, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[17]  B. Gersh,et al.  Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. , 2011, Journal of the American College of Cardiology.

[18]  F. Alfonso.  Multivessel intervention during primary angioplasty: too greedy? , 2010, JACC. Cardiovascular interventions.

[19]  Samin K. Sharma,et al.  Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. , 2010, JACC. Cardiovascular interventions.

[20]  G. Sangiorgi,et al.  A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up , 2009, Heart.

[21]  Sunil V. Rao,et al.  Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry). , 2009, The American journal of cardiology.

[22]  J. Rees.  Prevalence , 2005, BMJ : British Medical Journal.

[23]  D. Dudek,et al.  The function of the left ventricle after complete multivessel one-stage percutaneous coronary intervention in patients with acute myocardial infarction. , 2004, The Journal of invasive cardiology.

[24]  M. Bonardi,et al.  Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat™ for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study , 2004, International journal of cardiovascular interventions.

[25]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.